Pregabalin in the treatment of depression
by
Showraki M.
Community Psychiatrists Association of Toronto, Ontario, Canada.
communitypsychiatrists@sympatico.ca
J Psychopharmacol. 2007 Nov;21(8):883-4.


ABSTRACT

Although studies have demonstrated the efficacy of the new anti-epileptic on the block, Pregabalin, in the treatment of Generalized Anxiety Disorder and Social Anxiety Disorder, there is no study so far of such efficacy for the treatment of depression. This case study in a patient with chronic major depression demonstrates that Pregabalin could be an effective augmenting agent to other anti-depressants, e.g. SSRI's and SNRI's. This added property of Pregabalin may be related to its probable GABA-ergic mechanism of action that could be soon the emerging treatment pathway for achieving better remission in chronic depression that is yet clinically problematic.

Pregabalin
Alprazolam
Adinazolam
Barbiturates
Benzodiazepines
Future anxiolytics
Venlafaxine for GAD
Anxiety and depression
Subthreshold syndromes
Anxious golden hamsters
Buspirone plus venlafaxine
New anxiolytics: pregabalin
Generalised Anxiety Disorder (GAD)
Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety


Refs
and further reading

HOME
HedWeb
Nootropics
Cocaine.org
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family